key: cord-1032537-ewcqn7vh
authors: Santana, Genoile Oliveira; de Santana, Andréa Canário; Pfeilsticker, Vanessa Barto
title: Ileum Perforation in Crohn’s Disease Patient During SARS-Cov-2 Infection
date: 2020-11-30
journal: Inflamm Bowel Dis
DOI: 10.1093/ibd/izaa319
sha: 6f53079314268acf4904ef011fe24c12838adf00
doc_id: 1032537
cord_uid: ewcqn7vh

nan

To the Editors, Gastrointestinal and liver manifestations are described in approximately 15% of patients with coronavirus disease 2019 (COVID-19), and digestive comorbidities are reported in 4% of such patients. 1 To the best of our knowledge, only 1 case of small bowel perforation in a Crohn's disease (CD) patient infected by SARS-CoV-2 has been described. 2 We report a case of a CD patient in the remission phase who presented with a small bowel perforation during SARS-CoV-2 infection.

A 43-year-old male physician reported an anal abscess 10 years ago followed by self-limited episodes of diarrhea. He did not have any comorbidities. The symptoms intensified, and abdominal distension began 1 year ago. The MR enterography findings were suggestive of CD. The diagnosis was confirmed after a pathologic study of the ileum, which was resected 10 months prior. He did not present criteria for postoperative recurrence. Metronidazole was prescribed for 3 months. A new imaging study was scheduled for 6 months later. He was completely asymptomatic and postponed the evaluation because of the COVID-19 pandemic. Eleven days before hospital admission, he started showing symptoms such as dry cough, fever, coryza, and headache. After 4 days, he started to have anosmia, ageusia, and diarrhea and tested positive for SARS-CoV-2 infection. He was admitted to the emergency room, reporting sudden and severe abdominal pain for 6 hours without improvement despite taking analgesics. Imaging revealed pneumoperitoneum, and laparoscopic surgery was performed. A preoperative chest computed tomography scan revealed a consolidating focus with nodules and ground-glass opacities in the lower right lobe. Intraoperatively, a small amount of free, enteric-like fluid was identified, without pus, fibrin or peritonitis, which could suggest recent perforation. A friable terminal ileum was observed. Two perforated ulcers, 2 mm each, without inflammatory adhesions, were identified close to the previous enteric anastomosis, approximately 15 centimeters from the ileocecal valve. The affected segment was resected, and an end-to-end anastomosis was performed with nonabsorbable thread. The pathological features of the resected segment showed edema, vascular congestion, acute inflammation, perforation, and normal lymph nodes (Fig. 1) . After 11 days, he was discharged, asymptomatic, without sequelae, and a swab specimen tested negative for SARS-CoV-2 infection.

The occurrence of ileum perforation during SARS-CoV-2 infection in CD patients could be misinterpreted as disease activity in patients who are not under strict follow-up. The uncertainty about etiology could make the management of this threatening complication difficult. Our patient was in surgical remission from CD, and after recovering from SARS-CoV-2 infection, he remained completely asymptomatic. Furthermore, the surgical and pathological findings did not suggest CD activity. Staff of inflammatory bowel disease reference centers need to be aware of this possible complication in CD patients who acquire SARS-CoV-2 infection. 

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

Abdominal surgery in patients with COVID-19: detection of SARS-CoV-2 in abdominal and adipose tissues